RNWAX
Price
$75.97
Change
+$0.61 (+0.81%)
Updated
Jan 30 closing price
Net Assets
63.4B
TEMHX
Price
$8.01
Change
+$0.11 (+1.39%)
Updated
Jan 30 closing price
Net Assets
1.68B
Ad is loading...

RNWAX vs TEMHX

Header iconRNWAX vs TEMHX Comparison
Open Charts RNWAX vs TEMHXBanner chart's image
American Funds New World R1
Price$75.97
Change+$0.61 (+0.81%)
VolumeN/A
Net Assets63.4B
Nuveen Emerging Markets Eq I
Price$8.01
Change+$0.11 (+1.39%)
VolumeN/A
Net Assets1.68B
RNWAX vs TEMHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RNWAX vs. TEMHX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNWAX is a StrongBuy and TEMHX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RNWAX has more cash in the bank: 63.4B vs. TEMHX (1.68B). TEMHX pays higher dividends than RNWAX: TEMHX (3.16) vs RNWAX (0.61). RNWAX was incepted earlier than TEMHX: RNWAX (23 years) vs TEMHX (9 years). RNWAX is a more actively managed with annual turnover of: 32.00 vs. TEMHX (14.00). RNWAX has a lower initial minimum investment than TEMHX: RNWAX (250) vs TEMHX (100000). TEMHX (7.61) and RNWAX (7.47) have marching annual gain over last year. RNWAX return over 5 years is better than : 14.50 vs. TEMHX (-26.08).
RNWAXTEMHXRNWAX / TEMHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years9 years-
Gain YTD3.1781.542206%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets63.4B1.68B3,776%
Annual Yield % from dividends0.613.1619%
Returns for 1 year7.477.6198%
Returns for 3 years-0.88-8.9010%
Returns for 5 years14.50-26.08-56%
Returns for 10 years45.76N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRSN0.640.05
+8.47%
Mersana Therapeutics
BA179.535.87
+3.38%
Boeing Company
CEPU14.590.38
+2.67%
Central Puerto SA
HALO56.420.59
+1.06%
Halozyme Therapeutics
CMPX3.02-0.09
-2.89%
Compass Therapeutics